Navamedic ASA announced that the Board of Directors has appointed Kathrine Gamborg Andreassen as Chief Executive Officer. Ms. Gamborg Andreassen will assume her position effective January 1, 2019. Kathrine is a seasoned and experienced executive with an impressive track record in the pharma and healthcare field. Kathrine Gamborg Andreassen served as Chair of the Board of Navamedic from June until December 2018. Gamborg Andreassen was the CEO of Weifa ASA until the company was acquired by Karo Pharma AB in November 2017, and also served as VP Consumer Health at Weifa. Gamborg Andreassen is the co-owner and Chair of the Board at Novicus Pharma AS.